This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waisman, D.
Right arrow Articles by Bental, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waisman, D.
Right arrow Articles by Bental, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 104 No. 3 September 1999, pp. 579

Myoclonic Movements in Very Low Birth Weight Premature Infants Associated With Midazolam Intravenous Bolus Administration

The first 20% of the full text of this article appears below.

To the Editor.

Midazolam, a relatively new sedative and muscle relaxant that belongs to the benzodiazepine family, has lately started to be part of the arsenal of drugs used in the neonatal intensive care units.

There are a few reports and studies related to the benefits and safety of its use in premature infants. Few side effects were reported as . . . [Full Text of this Article]
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?